Followers | 40 |
Posts | 1920 |
Boards Moderated | 0 |
Alias Born | 11/08/2011 |
Thursday, February 20, 2020 9:19:27 AM
Neutra Corp. (NTRR) continues its efforts towards vertical integration, this time examining the potential of integrating technology into its hemp-based CBD enterprise. The company believes the time is right to add a technological dimension to its operation and that such an addition could lead to greater future growth and expansion opportunities.
BLAH, BLAH, BLAH....more meaningless jibberish about what they hope/pray/think/ponder about doing. Let's add an undefined "technology dimension" of unknown cost or benefit to our already non-existent operations with no assets, no money, no employees and no explanation as to where the millions of dollars have gone to date.
"This is a natural progression of our ongoing vertical integration push," - of course it is....more fluff about "vertical integration" with no results.
"Last year, we enjoyed success with the VIVIS acquisition that gave us a retail presence. We expect similar results in our efforts to acquire land and facilities for hemp cultivation. - At least he is being honest here stating he expects similar results of non-performance and continued dilution and degredation of shareholder value.
Adding a technology component to our growing mix would make us a stronger, more competitive company in control of the entire process from the field, to the lab to the retail store."- LOL - staying in control (of the personal ATM)….
Earlier this month, Neutra announced it had received a fresh round of private equity funding. These new funds could help the company partner with an existing CBD-related technology company or acquire one. A CBD-related technology company is typically involved in improving CBD delivery methods, such as boosting concentrations and increasing absorption rates. - WHEW - that sounds impressive..let's see what else we can throw at the wall to see what sticks. Acquiring an existing CBD-related company...you mean like Vivis - a company with no assets/employees/sales? BTW - what happened to the "acquisition" of a property that was supposed to close last month - I thought this fresh round of funding was going to be used for that?
The Hemp Business Journal has forecasted that by 2022, sales of hemp-derived products will reach $22 billion by 2022. Last year, that same market posted sales of $390 million. - yeah, and let's see...after the "success" of acquiring Vivis the sales were what again??? Oh yeah...ZERO
Recent NTRR News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 09:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/14/2023 08:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/04/2023 08:21:12 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM